溫州醫(yī)科大學(xué)祝建洪課題組2015年研究生調(diào)劑信息

課題組部分發(fā)表文章

1.Wang JY, Gong MY, Ye YL, Ye JM, Lin GL, Zhuang QQ, Zhang X*, Zhu JH*. (2015). The RIT2 and STX1B polymorphisms are associated with Parkinson's disease. Parkinsonism Rel. Disorders. 21:300-302.

2.Zhang X, Cheng X, Hu YB, Lai JM, You H, Hu PL, Zou M, Zhu JH*. (2014). Serotonin transporter polymorphic region 5-HTTLPR modulates risk for Parkinson’s disease. Neurobiol Aging. DOI:10.1016/j.neurobiolaging.2014.03.002.

3.Liu RP, Zou M, Wang JY, Zhu JJ, Lai JM, Zhou LL, Chen SF, Zhang X*, Zhu JH*. (2014). Paroxetine ameliorates lipopolysaccharide-induced microglia activation via differential regulation of MAPK signaling. J. Neuroinflamm. 11:47.

4.Zhao HW, Lin J, Wang XB, Cheng X, Wang JY, Hu BL, Zhang Y*, Zhang X*, Zhu JH*. (2013) Assessing plasma levels of selenium, copper, iron and zinc in patients of Parkinson’s disease. PLoS ONE. 8:e83060.

5.Zhu JH*, Chen CL, Flavahan S, Harr J, Su BY, Flavahan NA. (2011) Cyclic stretch stimulates vascular smooth muscle cell alignment by redox-dependent activation of Notch3. Am. J. Physiol. Heart Circ. Physiol. 300:H1770-H1780.

6.Zhu JH, Zhang X, Roneker CA, McClung JP, Zhang S, Thannhauser TW, Ripoll DR, Sun Q, Lei XG. (2008) Role of Cu,Zn-superoxide dismutase in catalyzing nitrotyrosine formation in murine liver. Free Radic. Biol. Med. 45:611-618.

7.Zhu JH, Chen R, Yi W, Cantin GT, Fearns C, Yang Y, Yates JR, Lee JD. (2008) Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling. Oncogene, 27:2525-2531.

溫馨提示：該信息自網(wǎng)絡(luò)渠道整理，未一一甄別其有效真實(shí)性，若有意向，請(qǐng)查看院校或聯(lián)系老師核實(shí)。若有不妥，請(qǐng)聯(lián)系我們刪除。刪除請(qǐng)聯(lián)系 tiaoji@163.com